Stonebridge Capital Advisors LLC lowered its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 1.4% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 3,550 shares of the company’s stock after selling 50 shares during the period. Stonebridge Capital Advisors LLC’s holdings in Colgate-Palmolive were worth $260,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Chickasaw Capital Management LLC boosted its stake in Colgate-Palmolive by 218.3% in the first quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock worth $1,238,000 after buying an additional 11,605 shares during the last quarter. Meritage Portfolio Management boosted its stake in Colgate-Palmolive by 0.3% in the first quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock worth $7,017,000 after buying an additional 255 shares during the last quarter. Eastern Bank boosted its stake in Colgate-Palmolive by 0.8% in the first quarter. Eastern Bank now owns 10,939 shares of the company’s stock worth $801,000 after buying an additional 89 shares during the last quarter. ProShare Advisors LLC boosted its stake in Colgate-Palmolive by 9.9% in the first quarter. ProShare Advisors LLC now owns 879,652 shares of the company’s stock worth $64,382,000 after buying an additional 79,323 shares during the last quarter. Finally, Lynch & Associates IN boosted its stake in Colgate-Palmolive by 4.1% in the first quarter. Lynch & Associates IN now owns 29,542 shares of the company’s stock worth $2,162,000 after buying an additional 1,175 shares during the last quarter. 73.69% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Company (NYSE:CL) traded up 0.34% during midday trading on Tuesday, hitting $71.69. The company had a trading volume of 771,185 shares. The firm’s 50 day moving average is $72.71 and its 200-day moving average is $72.83. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The firm has a market capitalization of $63.15 billion, a P/E ratio of 26.64 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The firm had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. During the same period last year, the firm earned $0.70 earnings per share. The company’s revenue for the quarter was down .5% compared to the same quarter last year. On average, equities research analysts expect that Colgate-Palmolive Company will post $2.89 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.24%. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.

TRADEMARK VIOLATION NOTICE: “Stonebridge Capital Advisors LLC Sells 50 Shares of Colgate-Palmolive Company (CL)” was published by Watch List News and is owned by of Watch List News. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://www.watchlistnews.com/stonebridge-capital-advisors-llc-sells-50-shares-of-colgate-palmolive-company-cl/1491197.html.

A number of analysts have recently issued reports on the company. Zacks Investment Research cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Royal Bank Of Canada reissued a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a report on Thursday, May 25th. UBS AG reissued a “neutral” rating and set a $78.00 price target (down from $79.00) on shares of Colgate-Palmolive in a report on Tuesday, May 2nd. BidaskClub cut Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 12th. Finally, Jefferies Group LLC reissued a “hold” rating and set a $79.00 price target (up from $77.00) on shares of Colgate-Palmolive in a report on Monday, July 24th. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the company’s stock. Colgate-Palmolive presently has a consensus rating of “Hold” and an average price target of $75.82.

In other news, SVP John J. Huston sold 14,000 shares of the stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $71.36, for a total transaction of $999,040.00. Following the completion of the sale, the senior vice president now directly owns 88,598 shares in the company, valued at $6,322,353.28. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Justin Skala sold 74,374 shares of the stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $72.51, for a total transaction of $5,392,858.74. Following the sale, the chief operating officer now owns 97,177 shares of the company’s stock, valued at $7,046,304.27. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 217,969 shares of company stock valued at $15,710,108. 1.02% of the stock is currently owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.